Evidence of meeting #41 for Health in the 45th Parliament, 1st session. (The original version is on Parliament’s site, as are the minutes.) The winning word was patients.

A video is available from Parliament.

On the agenda

Members speaking

Before the committee

Devin Schellenberg  Senior Executive Medical Director, Radiation Therapy and Medical Programs, BC Cancer
Housty  Vice President, Quality, Chief Nursing and Allied Health Officer, First Nations Health Authority
Mooder  Director, Provincial Clinical Innovation, Office of the Chief Nursing and Allied Health Officer, First Nations Health Authority
Sarah Giles  President, Rural Generalist Physician, Society of Rural Physicians of Canada
Carson  Chief Executive Officer, Breast Cancer Canada
Topham  Director, Advocacy and Communications, Canadian Association of Medical Radiation Technologists
Alison Harris  President, Canadian Association of Radiologists

12:45 p.m.

President, Canadian Association of Radiologists

Dr. Alison Harris

We've highlighted the fact that there are problems with system integration. Yes, I think if a patient is travelling across the country, having access to whatever imaging they've had in another jurisdiction would be important. Even having it just within provinces would be a big step forward.

Doug Eyolfson Liberal Winnipeg West, MB

Thank you.

I'm going to change gears a bit.

Mr. Topham, thank you for what you do.

One of the heartbreaking things I've noticed—I'll say frustrating things—is this. I used to fly for air ambulances. Very often, we had to pick someone up because they had a head injury in a centre that had a CT scanner, but they presented at 4:15 and the scanner closed at four due to a lack of staff. That was in a lot of places.

I know there are a lot of vacancies, and it is likely more acute in smaller, more isolated and northern centres. Are there innovations in training so that instead of having to send people down to a major centre for training...? If you have an MRI in Thompson, Manitoba, and there's someone locally who wants to do it, are there provisions so that a large portion of that training can be done remotely and local people can be trained to do this?

12:45 p.m.

Director, Advocacy and Communications, Canadian Association of Medical Radiation Technologists

Christopher Topham

Yes, there are. Traditionally, programs have been run from the universities or the colleges, and people have had to spend a substantial amount of time in classrooms there. Clinical placements have always been spread around. I'm not saying that they've been in Thompson in particular, but people have been able to do the clinical portion of their education spread around the country.

As we're able to do more virtual classroom work, there are people innovating in that area to ensure that people would have to do very little time in classrooms at their colleges, so they would then be able to do virtual didactic work and then clinical work in various sites spread across a province or even the country.

Doug Eyolfson Liberal Winnipeg West, MB

Thank you.

Is there a role in some of these centres, which might have lower volumes for other types of clinical problems or tasks, to cross-train people so that people who are working in one associated area can receive some of this training remotely so they can stay in the community? Is that happening, or is that a possibility?

November 2nd, 2026 / 12:45 p.m.

Director, Advocacy and Communications, Canadian Association of Medical Radiation Technologists

Christopher Topham

I think an example of that would be cross-training in laboratory and X-ray, for example. Yes, that's happening quite extensively across the country because of the rural nature of Canada. There's a well-defined model for that.

Doug Eyolfson Liberal Winnipeg West, MB

That's my time. Thank you very much.

The Chair Liberal Sukh Dhaliwal

That was exactly six minutes.

We'll go to Madame Gaudreau for six minutes.

Marie-Hélène Gaudreau Bloc Laurentides—Labelle, QC

Thank you very much, Mr. Chair.

I am grateful for the witnesses' valuable recommendations.

Is the interpretation working properly? I'll take a moment to make sure, because my first question is for you, Ms. Carson. Is everything clear for you? Perfect.

Indeed, when it comes to breast cancer screening—I'm not familiar with the situation across all provinces and territories, but when we decide to act in good time—I'm thinking, amongst other places, of Quebec, where we're currently looking into colorectal cancer screening, which we're not yet in a position to prevent—the earlier we screen, the longer life expectancy becomes.

What do the health ministers of the other provinces and territories say about your desire to have the most resilient network possible?

12:50 p.m.

Chief Executive Officer, Breast Cancer Canada

Kimberly Carson

What we, other provinces and territories and any health ministers I'm speaking to at that level, are looking at is, the sooner we can catch it and know what we can put in place in the way of screening and detection, the better the outcomes. What can we put in place? What technologies are coming? What AI-supported initiatives can we put in place to make that initial detection as early as possible for any of our cancer people, whether it's colorectal, breast or any of your FIT tests? There's early detection now with lungs.

We're also now looking at a new test. It will be a liquid biopsy, a blood test that's coming. We're currently waiting on the FDA to approve that. The independent advisory committee to the FDA has suggested that the FDA approve that, and it will be that initial screening for about 50 different types of cancer. That's being watched very closely. It is available in some of the provinces now through private clinics and through insurance companies. A lot of them are paying for it now. The push is towards the concept that, the earlier we detect it, the better the outcomes, the less impact on the patient and the less impact on the system.

Through our research, we know there's a financial toxicity to any kind of cancer diagnosis. We're looking at how we decrease that, particularly for women in the breast cancer space under the age of 55 who are financially impacted quite significantly with a breast cancer diagnosis. The earlier we can catch it, the better the outcomes for the patient, the less financial toxicity and the better for the system overall. That's what we're looking at.

Marie-Hélène Gaudreau Bloc Laurentides—Labelle, QC

As I was saying earlier, indeed, when I see that it is hospital foundations that are raising several million dollars to gain access to equipment, I have one wish: let us focus on technological development to achieve breakthroughs, particularly with blood tests. Let us provide both the practical expertise and the machinery we need—which we could make available to the whole community.

Thank you, Ms. Carson.

My question is for you, Dr. Harris. I, too, am curious to know what the thirteen provincial and territorial governments and ministers have to say about the $2 billion investment over three years that you mentioned. What do they say about it?

12:50 p.m.

President, Canadian Association of Radiologists

Dr. Alison Harris

We would recommend ideally a federal strategy for equipment. Any funding that is allocated for medical imaging equipment would need to be distributed based on need. There would also need to be accountability. If equipment is going to be funded by the federal government, as I think it was 20 years ago or so, then there would need to be accountability by the provinces.

Now, the funding for the actual equipment is not just for the piece of machinery. There are quite a lot of additional costs for the room renovations. There has to be a lot of preparation to put in a big piece of equipment like MRI or CT equipment. The operational costs also have to be taken into consideration, plus the technologists' needs.

Marie-Hélène Gaudreau Bloc Laurentides—Labelle, QC

I have a question. It's as if trust were lacking. I'll say it: when I speak to our specialists, both in rural areas and in major research centres, they tell me that there's always someone there watching and judging them. They know what they need, and they also have the expertise.

So, obviously, as far as Quebec is concerned, when it comes to accountability, we'll say “no, thank you”, and that we'll continue to make efforts. However, is it conceivable to increase health transfers to enable the provinces and territories to acquire what they need? Is this a viable option, or do you completely disagree?

The Chair Liberal Sukh Dhaliwal

You have 15 seconds.

12:55 p.m.

President, Canadian Association of Radiologists

Dr. Alison Harris

I absolutely agree with what you've just said. I think the federal government should be working closely with the provinces to assess what the individual needs are.

The Chair Liberal Sukh Dhaliwal

Thank you very much.

Madam Dancho, you have four minutes.

12:55 p.m.

Conservative

Raquel Dancho Conservative Kildonan—St. Paul, MB

Thank you very much.

Ms. Carson, I have a few questions for you.

I want to talk about the real human impacts of long diagnostic wait times. At the outset of this, you mentioned that 32,000 women will be diagnosed in Canada this year, and 5,400 will pass away from their disease. That's about 15 women per day. About one in eight women will get breast cancer at some point in their life.

I remember that when we first met, you talked about the different stages of breast cancer. Please correct me, but my takeaway was that for stages 1 to 2, you have an excellent fighting chance if you can catch it at that stage. If it hits stages 3 and 4, you may very well be in for the fight of your life. Is that an accurate assessment of the way in which breast cancer progresses? How quickly can late stage 2 to stage 3 happen?

12:55 p.m.

Chief Executive Officer, Breast Cancer Canada

Kimberly Carson

Yes, absolutely, we're looking at anything between stage zero to stage 2 as a fairly curable rate five years out. Anything beyond that is a little bit more heavy lifting, I guess, for the patient and for the system, where the patients are experiencing more chemical toxicities from the disease progression. The system is having to respond with much more invasive treatment.

All our treatments are targeted treatments now. When a patient is diagnosed with a type of breast cancer, the type and stage will direct the treatment pathway that the patient is going to take. Certainly, the more advanced the stage of breast cancer, the more treatment will be required.

12:55 p.m.

Conservative

Raquel Dancho Conservative Kildonan—St. Paul, MB

What do the wait times look like across Canada? I know that from some of the experiences I've seen in Manitoba, it's about four or five months to get from referral to mammogram. Is that a good benchmark globally? Are we doing well there? Is it the same case across the country? What are we looking at nationally?

12:55 p.m.

Chief Executive Officer, Breast Cancer Canada

Kimberly Carson

Nationally, you're looking at very different outcomes depending on where you are. Certainly, as has been mentioned a number of times, our rural population is looking at much longer wait times, having to travel much further to have those treatments done and be away from home much longer. Again, that financial toxicity comes into play in how we manage all of that.

The wait times across the country really vary on where you're located. It's still a bit of a postal code lottery. From Breast Cancer Canada's point of view, we're trying to bring in a standard that looks like guidelines on how patients should be treated so that we can get those patients the same care no matter where they live in Canada with the REAL alliance. Our REAL alliance will be able to provide that pathway to care a lot faster for patients when it's clearer what they need based on their stage and type of breast cancer.

12:55 p.m.

Conservative

Raquel Dancho Conservative Kildonan—St. Paul, MB

Is there a benchmark for a lead time from the initial physician referral to a mammogram? Is there a global leader?

What's our goal, ultimately?

12:55 p.m.

Chief Executive Officer, Breast Cancer Canada

Kimberly Carson

I think our goal is less than seven weeks.

12:55 p.m.

Conservative

Raquel Dancho Conservative Kildonan—St. Paul, MB

What percentage of Canada would you say is meeting this seven-week referral benchmark?

12:55 p.m.

Chief Executive Officer, Breast Cancer Canada

Kimberly Carson

Unfortunately, no one is.

12:55 p.m.

Conservative

Raquel Dancho Conservative Kildonan—St. Paul, MB

No one is meeting the benchmark, yet one in eight women gets this terrible disease, and 5,400 women die annually, or 15 a day. Good work by this committee, by you and by others resulted in the recommendation, although it's not official in many provinces, that we should lower the initial mammogram age from 50 to 40, which is really great for women. I think it will save a lot of lives.

My concern is this: If we're already overtaxed at 50, are you hearing of any plans from provinces to prepare for those additional tests? What are we going to do so that we can all get them at age 40 going forward?

12:55 p.m.

Chief Executive Officer, Breast Cancer Canada

Kimberly Carson

There are a number of different initiatives being brought in.

Do we start to look at the risk score of women at a younger age? Do we start to look at ages 25 to 30 and do a risk score factor at that age to say whether we need to screen them at 40 or if they can wait? Do they have to be screened every two years, or should it be every year or every five years?